TCR2 Therapeutics Inc (NASDAQ:TCRR)
| 2.35 BATS BZX Real-Time Price As of May 13 |  0.00 / 0.00%Today’s Change | 2.10 Today|||52-Week Range 20.26 | -49.57% Year-to-Date |
Latest TCRR News | Press Releases
No recent news for TCR2 Therapeutics Inc.
Today’s Trading
| Previous close | 2.35 |
| Today’s open | 2.42 |
| Day’s range | 2.35 - 2.50 |
| Volume | 14,271 |
| Average volume (3 months) | 598,503 |
| Market cap | $90.6M |
Data as of 4:00pm ET, 05/13/2022
Growth & Valuation
| Earnings growth (last year) | -9.71% |
| Earnings growth (this year) | -13.55% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.32 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DRRXDURECT Corp | 0.00 | 0.00% |
| FBIOFortress Biotech Inc | 0.00 | 0.00% |
| DAREDare Bioscience Inc | 0.00 | 0.00% |
| EVLOEvelo Biosciences In... | 0.00 | 0.00% |
Data as of 4:00pm ET, 05/13/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.79 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$99.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
